Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,072 | 53 | 97.6% |
| Education | $26.52 | 1 | 2.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $140.51 | 9 | $0 (2020) |
| Sirtex Medical Inc | $140.20 | 1 | $0 (2019) |
| AstraZeneca Pharmaceuticals LP | $138.38 | 2 | $0 (2019) |
| Bayer HealthCare Pharmaceuticals Inc. | $124.86 | 8 | $0 (2019) |
| E.R. Squibb & Sons, L.L.C. | $112.88 | 8 | $0 (2019) |
| EISAI INC. | $96.31 | 5 | $0 (2019) |
| Janssen Biotech, Inc. | $68.79 | 4 | $0 (2019) |
| Ipsen Biopharmaceuticals, Inc | $28.42 | 2 | $0 (2019) |
| AbbVie Inc. | $28.34 | 2 | $0 (2020) |
| Blue Earth Diagnostics Limited | $26.52 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $25.53 | 1 | GE HealthCare ($25.53) |
| 2020 | $49.35 | 3 | Medtronic Vascular, Inc. ($22.60) |
| 2019 | $553.42 | 20 | Sirtex Medical Inc ($140.20) |
| 2018 | $204.05 | 14 | E.R. Squibb & Sons, L.L.C. ($43.42) |
| 2017 | $265.89 | 16 | Celgene Corporation ($65.67) |
All Payment Transactions
54 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/16/2022 | GE HealthCare | — | Food and Beverage | Cash or cash equivalent | $25.53 | General |
| 02/04/2020 | Medtronic Vascular, Inc. | CoreValve Evolut (Device) | Food and Beverage | In-kind items and services | $22.60 | General |
| Category: Transcatheter Valve Systems | ||||||
| 01/23/2020 | Celgene Corporation | Idhifa (Drug), INREBIC | Food and Beverage | Cash or cash equivalent | $12.93 | General |
| Category: Hematology | ||||||
| 01/15/2020 | AbbVie Inc. | VENCLEXTA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: ONCOLOGY | ||||||
| 12/03/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Oncology | ||||||
| 11/21/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $13.79 | General |
| Category: Oncology | ||||||
| 11/19/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $16.91 | General |
| Category: Oncology | ||||||
| 09/26/2019 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $18.32 | General |
| Category: Oncology | ||||||
| 08/29/2019 | Janssen Biotech, Inc. | DARZALEX (Biological), IMBRUVICA | Food and Beverage | In-kind items and services | $19.39 | General |
| Category: Oncology | ||||||
| 08/08/2019 | Celgene Corporation | Abraxane (Drug) | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Oncology | ||||||
| 08/01/2019 | Ipsen Biopharmaceuticals, Inc | SOMATULINE DEPOT (Drug), ONIVYDE | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: Oncology/Endocrinology | ||||||
| 07/25/2019 | GENZYME CORPORATION | CABLIVI (Drug) | Food and Beverage | In-kind items and services | $12.90 | General |
| Category: RARE BLOOD DISORDERS | ||||||
| 06/12/2019 | AstraZeneca Pharmaceuticals LP | IMFINZI (Drug) | Food and Beverage | In-kind items and services | $123.48 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 06/06/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $17.28 | General |
| Category: Oncology | ||||||
| 05/30/2019 | Celgene Corporation | Pomalyst (Drug) | Food and Beverage | In-kind items and services | $18.35 | General |
| Category: Hematology / Oncology | ||||||
| 05/16/2019 | Bayer HealthCare Pharmaceuticals Inc. | Xofigo (Drug) | Food and Beverage | In-kind items and services | $19.15 | General |
| Category: Oncology | ||||||
| 04/24/2019 | Janssen Biotech, Inc. | Balversa (Drug) | Food and Beverage | In-kind items and services | $12.72 | General |
| Category: Oncology | ||||||
| 04/11/2019 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $13.45 | General |
| Category: Oncology | ||||||
| 03/26/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $14.99 | General |
| Category: Oncology | ||||||
| 03/04/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $140.20 | General |
| Category: Interventional Oncology | ||||||
| 02/28/2019 | Spectrum Pharmaceuticals Inc. | Folotyn (Drug) | Food and Beverage | In-kind items and services | $12.13 | General |
| Category: Oncology | ||||||
| 02/13/2019 | TESARO, Inc. | ZEJULA (Drug) | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: ONCOLOGY | ||||||
| 01/31/2019 | AbbVie, Inc. | Venclexta (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Virology | ||||||
| 01/15/2019 | EISAI INC. | Lenvima (Drug) | Food and Beverage | Cash or cash equivalent | $23.04 | General |
| Category: Oncology | ||||||
| 10/18/2018 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Food and Beverage | Cash or cash equivalent | $15.90 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 26 | 2,119 | 2,661 | $197,377 | $49,376 |
| 2022 | 27 | 1,990 | 2,686 | $237,919 | $58,487 |
| 2021 | 21 | 1,591 | 1,987 | $205,706 | $53,000 |
| 2020 | 28 | 1,532 | 1,902 | $211,522 | $56,682 |
All Medicare Procedures & Services
137 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Facility | 2023 | 124 | 148 | $54,908 | $13,702 | 25.0% |
| 78815 | Nuclear medicine study from skull base to mid-thigh with ct scan | Office | 2023 | 109 | 127 | $47,117 | $11,734 | 24.9% |
| 71045 | X-ray of chest, 1 view | Facility | 2023 | 532 | 918 | $27,540 | $6,464 | 23.5% |
| 78816 | Nuclear medicine study whole body with ct scan | Facility | 2023 | 22 | 24 | $9,120 | $2,256 | 24.7% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 195 | 195 | $5,850 | $1,896 | 32.4% |
| 78816 | Nuclear medicine study whole body with ct scan | Office | 2023 | 15 | 16 | $6,080 | $1,509 | 24.8% |
| 78306 | Nuclear medicine study of bone and/or joint whole body | Facility | 2023 | 41 | 43 | $5,504 | $1,404 | 25.5% |
| 71046 | X-ray of chest, 2 views | Facility | 2023 | 161 | 164 | $5,904 | $1,286 | 21.8% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Facility | 2023 | 123 | 123 | $3,690 | $1,202 | 32.6% |
| 74018 | X-ray of abdomen, 1 view | Facility | 2023 | 63 | 91 | $2,730 | $662.13 | 24.3% |
| 78582 | Nuclear medicine study of lung ventilation and circulation | Facility | 2023 | 16 | 16 | $2,720 | $657.73 | 24.2% |
| 73564 | X-ray of knee, 4 or more views | Office | 2023 | 64 | 72 | $2,345 | $638.57 | 27.2% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 63 | 63 | $2,268 | $508.03 | 22.4% |
| 73030 | X-ray of shoulder, minimum of 2 views | Facility | 2023 | 62 | 73 | $2,070 | $483.98 | 23.4% |
| 78226 | Nuclear medicine study of liver and bile duct system | Facility | 2023 | 15 | 15 | $1,800 | $431.87 | 24.0% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 49 | 55 | $1,560 | $406.51 | 26.1% |
| 73564 | X-ray of knee, 4 or more views | Facility | 2023 | 33 | 40 | $1,260 | $377.16 | 29.9% |
| 74221 | Double contrast x-ray of esophagus | Facility | 2023 | 13 | 13 | $1,495 | $361.66 | 24.2% |
| 73502 | X-ray of hip, 2-3 views | Office | 2023 | 42 | 43 | $1,505 | $356.10 | 23.7% |
| 73562 | X-ray of knee, 3 views | Office | 2023 | 27 | 33 | $900.00 | $262.59 | 29.2% |
| 73630 | X-ray of foot, minimum of 3 views | Facility | 2023 | 27 | 36 | $806.00 | $234.92 | 29.1% |
| 73562 | X-ray of knee, 3 views | Facility | 2023 | 21 | 30 | $810.00 | $226.21 | 27.9% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Facility | 2023 | 27 | 27 | $945.00 | $224.61 | 23.8% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 23 | 23 | $805.00 | $204.27 | 25.4% |
| 73502 | X-ray of hip, 2-3 views | Facility | 2023 | 25 | 25 | $875.00 | $188.22 | 21.5% |
About Dr. Khozaim Nakhoda, MD
Dr. Khozaim Nakhoda, MD is a Diagnostic Radiology healthcare provider based in Upland, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/07/2005. The National Provider Identifier (NPI) number assigned to this provider is 1700870789.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Khozaim Nakhoda, MD has received a total of $1,098 in payments from pharmaceutical and medical device companies, with $25.53 received in 2022. These payments were reported across 54 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($1,072).
As a Medicare-enrolled provider, Nakhoda has provided services to 7,232 Medicare beneficiaries, totaling 9,236 services with total Medicare billing of $217,546. Data is available for 4 years (2020–2023), covering 137 distinct procedure/service records.
Practice Information
- Specialty Diagnostic Radiology
- Location Upland, PA
- Active Since 09/07/2005
- Last Updated 03/08/2011
- Taxonomy Code 2085R0202X
- Entity Type Individual
- NPI Number 1700870789
Products in Payments
- SIR-Spheres Microspheres (Device) $140.20
- IMFINZI (Drug) $123.48
- OPDIVO (Biological) $112.88
- Xofigo (Drug) $112.19
- Revlimid (Drug) $78.61
- Lenvima (Drug) $77.39
- DARZALEX (Biological) $38.50
- Pomalyst (Drug) $34.73
- Axumin (Drug) $26.52
- CoreValve Evolut (Device) $22.60
- Halaven (Drug) $18.92
- AFINITOR (Drug) $18.82
- Nerlynx (Drug) $18.32
- IMBRUVICA (Drug) $17.57
- SOMATULINE DEPOT (Drug) $16.65
- Iclusig (Drug) $15.90
- TAGRISSO (Drug) $14.90
- Venclexta (Drug) $14.52
- ZEJULA (Drug) $14.45
- Abraxane (Drug) $14.24
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Diagnostic Radiology Doctors in Upland
Lorna Blum, M.d, M.D
Diagnostic Radiology — Payments: $978,753
John Hiehle, Md, MD
Diagnostic Radiology — Payments: $1,310
Gregory Schwartzman, Md, MD
Diagnostic Radiology — Payments: $952.66
Dr. David Dang, M.d, M.D
Diagnostic Radiology — Payments: $599.73
Dr. Damon Soeiro, Md, MD
Diagnostic Radiology — Payments: $515.92
Justin Blum, M.d, M.D
Diagnostic Radiology — Payments: $490.36